)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
BIOLASE
BIOLASE (BIOL) investor relations material
BIOLASE has been otc
BIOLASE Q3 2024 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2024 earnings summary6 Nov, 2024
Executive summary
Net revenue for Q3 2024 was $10.9M, nearly flat year-over-year; nine-month revenue declined 9% to $32.5M due to lower laser system sales, partially offset by higher consumables and services.
Net loss narrowed to $1.4M for Q3 2024 from $4.6M in Q3 2023; nine-month net loss improved to $10.7M from $15.3M year-over-year.
On October 1, 2024, BIOLASE and subsidiaries filed for Chapter 11 bankruptcy; operations continue as debtors-in-possession.
MegaGen Implant Co., LTD won the auction to acquire substantially all assets for $20.5M, subject to court approval.
Company delisted from Nasdaq in June 2024 and from OTCQB in October 2024; now trades on OTC Pink Market.
Financial highlights
Gross profit margin improved to 40% in Q3 2024 from 34% in Q3 2023, driven by lower warranty, service, and freight costs.
Operating expenses fell 32% year-over-year in Q3 2024, mainly from cost savings in sales, marketing, and G&A.
Cash and cash equivalents were $3.4M at September 30, 2024, down from $6.6M at year-end 2023.
Working capital deficit was $11.4M at September 30, 2024, compared to $5.2M working capital at December 31, 2023.
Adjusted EBITDA for Q3 2024 was $(3.1)M, an improvement from $(6.0)M in Q3 2023.
Outlook and guidance
Management expresses substantial doubt about the ability to continue as a going concern due to recurring losses, negative cash flow, and bankruptcy proceedings.
Additional capital will be required; ability to raise funds is uncertain, especially after delisting from major exchanges.
Company expects to continue operations during bankruptcy and pursue asset sale to MegaGen, pending court approval.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
BIOLASE
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
BIOLASE, Inc. is a medical device company that specializes in the development and manufacturing of laser systems for dental care. The company's products include dental lasers used in a variety of procedures, such as cosmetic dentistry, surgery, and pain management. BIOLASE's lasers are designed to improve precision, reduce patient discomfort, and enhance recovery times. The company serves dental professionals and healthcare providers, aiming to offer advanced technological solutions for oral health treatments. The company is headquartered in Lake Forest, United States, and its shares are listed on the NASDAQ.